Heart failure trials in Poland
68 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Gdansk
- Age
- 29 days to 17 years
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - No phaseTaking peopleEndovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection Fraction
- Where
- Wroclaw
- Age
- 40 years and over
- People
- 50 worldwide
- Run by
- Axon Therapies, Inc.
See details and how to joinNCT07403058 - Phase 2Not yet taking people in PolandA Study of Bimagrumab in Participants With HFpEF
- Where
- Krakow, Wroclaw
- Age
- 18 years and over
- People
- 540 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07920887 · EU 2026-527983-34-00 - No phaseTaking peopleRemote Rehabilitation in Patients With HFpEF (PATRON-HF)
- Where
- Chrzanów, Katowice, Tychy
- Age
- 40 years and over
- People
- 110
- Run by
- American Heart of Poland
See details and how to joinNCT07918209 - No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Poznan, Warsaw, Zabrze
- People
- 20,000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - Phase 3Taking peopleStudy With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- Where
- Bialystok, Cracow, Lodz, Miechów, Opole, Poznan, Ruda Śląska, Świdnik, Torun, Warsaw, Wrocław
- Age
- 18 years to 85 years
- People
- 1,800 worldwide
- Run by
- Cytokinetics
See details and how to joinNCT06736574 · EU 2024-519219-32-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Bialystok, Bydgoszcz, Chrzanów, Elblag, Gdansk, Gdynia, Giżycko, Katowice, Krakow, Lodz, Lublin, Miechów, Olsztyn, Oświęcim, Rzeszów, Skierniewice, Skorzewo, Torun, Tychy, Warsaw, Wroclaw, Żarów
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - No phaseTaking peopleVsling™ III: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart Failure
- Where
- Krakow
- Age
- 18 years to 85 years
- People
- 10
- Run by
- Cardiac Success
See details and how to joinNCT06002386 - Phase 3Taking peopleA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Bialystok, Bydgoszcz, Chojnice, Cracow, Częstochowa, Debica, Elblag, Gdańsk, Gdynia, Katowice, Krakow, Legnica, Lodz, Łódź, Lublin, Olsztyn, Piaseczno, Poznań, Ruda Śląska, Rzeszow, Siedlce, Skierniewice, Sochaczew, Staszow, Szczecin, Warsaw, Wroclaw, Żarów
- Age
- 18 years and over
- People
- 6,712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288 · EU 2023-509706-30-00 - Phase 3Taking peopleA Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Bielsko-Biala, Bydgoszcz, Cracow, Gdynia, Krakow, Legnica, Lodz, Lublin, Piaseczno, Plock, Poznan, Rzeszow, Siedlce, Skierniewice, Staszow, Szczecin, Warsaw, Wroclaw, Wrocław, Zamość, Żarów
- Age
- 18 years and over
- People
- 4,200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370 · EU 2024-519525-38-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Bialystok, Białystok, Bydgoszcz, Chrzanów, Cracow, Elblag, Gdansk, Gdynia, Gizycko, Katowice, Lodz, Lublin, Miechów, Olsztyn, Ostrów Mazowiecka, Oswiecim, Rzeszow, Skierniewice, Skorzewo, Torun, Tychy, Warsaw, Warszawa, Wroclaw, Żarów
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - Phase 3Taking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Katowice, Lodz, Warsaw, Wroclaw
- Age
- Up to 18 years
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - Phase 2Taking peopleA Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Where
- Bydgoszcz, Katowice, Olsztyn, Poznan, Pulawy, Sopot, Torun
- Age
- 18 years to 79 years
- People
- 620 worldwide
- Run by
- Pfizer
See details and how to joinNCT06991257 · EU 2024-518438-94-00 - Phase 3Taking peoplePhase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Biala Podlaska, Bialystok, Chojnice, Chrzanów, Cracow, Czestochowa, Gdansk, Gdynia, Jaslo, Katowice, Krakow, Lodz, Lublin, Myszkow, Olsztyn, Ostrów Mazowiecka, Piekary Slaskie, Plock, Poznan, Przemyśl, Radzionkow, Rzeszów, Skorzewo, Szczecin, Tarnów, Torun, Warsaw, Warszawa, Wroclaw, Zabrze
- Age
- 40 years and over
- People
- 11,300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060 · EU 2024-514506-32-00 - Phase 3Taking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Gdansk, Poznan, Warsaw
- Age
- 18 years and over
- People
- 1,280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - No phaseTaking peopleCytOSorb TreatMent Of Critically Ill PatientS Registry
- Where
- Krakow, Wroclaw
- People
- 3,000 worldwide
- Run by
- CytoSorbents, Inc
See details and how to joinNCT05146336 - No phaseTaking peopleThe Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- Where
- Bialystok, Katowice
- Age
- 18 years and over
- People
- 754 worldwide
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370 - Phase 3Taking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Katowice, Lodz, Warsaw, Wroclaw
- Age
- 6 months to 17 years
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - Phase 3Taking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Biała Podlaska, Bielsko-Biala, Bydgoszcz, Chrzanów, Gdansk, Gdynia, Katowice, Kazimierza Wielka, Kędzierzyn-Koźle, Krakow, Lodz, Lublin, Olsztyn, Ostrów Mazowiecka, Piekary Śląskie, Poznan, Rzeszów, Szczecin, Tarnów, Torun, Tychy, Warsaw, Wroclaw, Zabrze
- Age
- 18 years to 130 years
- People
- 3,850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleFluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
- Where
- Bialystok, Lodz, Wroclaw
- Age
- 22 years and over
- People
- 400 worldwide
- Run by
- Reprieve Cardiovascular, Inc
See details and how to joinNCT06898515 - No phaseTaking peopleAlleviant ALLAY-HFrEF Study
- Where
- Opole, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 350 worldwide
- Run by
- Alleviant Medical, Inc.
See details and how to joinNCT06812533 - Phase 3Taking peopleMulti-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- Where
- Bialystok, Bydgoszcz, Cracow, Gdansk, Gdynia, Katowice, Krakow, Lodz, Lublin, Myszkow, Opole, Poznan, Przemyśl, Rzeszow, Torun, Tychy, Warsaw, Wejherowo, Wroclaw, Zabrze, Zgierz
- Age
- 18 years and over
- People
- 1,900 worldwide
- Run by
- Pharmacosmos A/S
See details and how to joinNCT06929806 · EU 2024-519059-28-00 - Phase 2Taking peopleA Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Bialystok, Bielsko-Biala, Cracow, Lodz, Lublin, Przemyśl, Szczecin, Warsaw, Wroclaw, Wrocław, Zabrze
- Age
- 40 years to 84 years
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979362 · EU 2024-515796-35-00 - No phaseNot yet taking people in PolandRemote Monitoring and Optimization of Heart Failure Therapy
- Where
- Warsaw
- Age
- 18 years to 85 years
- People
- 800 worldwide
- Run by
- Zoll Medical Corporation
See details and how to joinNCT07622472 - No phaseTaking peoplePatient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation
- Where
- Zabrze
- Age
- 18 years and over
- People
- 2,600 worldwide
- Run by
- Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07852221